CTTH - CTT Pharma Announces Mexico Patent Allowed
(TheNewswire)
Tampa, Florida, United States –TheNewswire - March 30, 2022 - CTT Pharmaceutical Holdings, Inc.( OTC: CTTH) has expanded its reach into additionalinternational markets with a successful patent application of its OralStrip drug delivery system in Mexico. This allowed patent covers our"Oral Strip" delivery system, which utilizes micelles todeliver accurate and reliable active ingredient dosages rapidly. Theapplication of micelles in drug delivery is a powerful alternative fordissolving hydrophobic drugs in aqueous environments, minimizing drugdegradation and loss, preventing harmful side effects, and increasingdrug bioavailability. This patent is ideal for various medical APIs,including THC, CBD, nicotine, and many other cannabinoids for themarket in Mexico. By increasing our geographic footprint, CTT Pharmacontinues to pursue its new strategy of monetizing its IP throughpartnerships for its drug delivery technology in many of the world'smost rapidly growing markets.
“Our smoke-free alternative creates an opportunityfor CTT and futures partners in Mexico, as our technology gives us adistinct advantage in the delivery of THC, CBD, and many othercannabinoids by bypassing the lungs and digestive tract including theliver,” said Ryan Khouri, CEO of CTT Pharma.
CTT is a drug delivery technologycompany that successfully received Health Canada approval, after whichit brought its first product to market as cannabinoid-infused"Dissolve Strips". This successful launch sold out to only85,000 medical patients online with no advertising in several weeks.
CTT common shares trade on the OTCmarket in the United States under the symbol "CTTH".
Contact Ryan Khouri at 813-606-0060
Rkhouri@cttpharmaceuticals.com
Copyright (c) 2022 TheNewswire - All rights reserved.